Fenofibrate Pellets
Fenofibrate Pellets – Pharmaceutical Pellets for Antilipemic Formulation Development. Rraynex Fenofibrate Pellets are manufactured for pharmaceutical companies developing lipid-lowering formulations requiring a consistent pellet platform. Controlled processing supports uniform active distribution and reliable capsule filling.
Product overview
Fenofibrate is an antilipemic agent supplied as pellets for multiparticulate manufacturing. Rraynex focuses on controlled pellet morphology, flow, and physical integrity to support downstream pharmaceutical processing. Technical specifications are available upon request.
Key characteristics
- Uniform active distribution across the pellet matrix.
- Controlled pellet morphology for downstream processing.
- Suitable for capsule filling and multiparticulate dosage forms.
- Technical support for formulation development and commercial supply.
Product specifications
- Product
- Fenofibrate Pellets
- Form
- Pellets
- Therapeutic category
- Antilipemic Agent
- Strength
- 66%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Fenofibrate Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities